| Michael Collins Hadley, PA-C | |
|
200 S Herlong Ave Ste B, Rock Hill, SC 29732-1182 | |
| (803) 324-1950 | |
| (803) 324-1933 |
| Full Name | Michael Collins Hadley |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 12 Years |
| Location | 200 S Herlong Ave Ste B, Rock Hill, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417209610 | NPI | - | NPPES |
| 006576 | Other | GA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | 006576 (Georgia) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | 2274 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Au Medical Center | Augusta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Au Medical Associates Inc | 9931013513 | 577 |
News Archive
Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.
The RABBIT risk score can predict the likelihood of serious infection in rheumatoid arthritis patients using tumor necrosis factor-alpha inhibitors and disease-modifying antirheumatic drugs, research confirms.
Cancer researchers at the University of Pittsburgh School of Medicine and Indiana University received a five-year, $3 million grant from the National Cancer Institute (NCI) to study cognitive dysfunction after chemotherapy.
AstraZeneca today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). SYMBICORT is currently approved for the long-term maintenance treatment of asthma in patients 12 years and older.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Collins Hadley, PA-C 1120 15th St Ste Bi1056, Augusta, GA 30912-0004 Ph: (706) 721-3813 | Michael Collins Hadley, PA-C 200 S Herlong Ave Ste B, Rock Hill, SC 29732-1182 Ph: (803) 324-1950 |
News Archive
Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.
Recreational ketamine use and availability of the drug have increased in recent years, but it remains an uncommon drug used by less than 1 percent of people in the U.S., according to a new study published in the American Journal of Public Health.
The RABBIT risk score can predict the likelihood of serious infection in rheumatoid arthritis patients using tumor necrosis factor-alpha inhibitors and disease-modifying antirheumatic drugs, research confirms.
Cancer researchers at the University of Pittsburgh School of Medicine and Indiana University received a five-year, $3 million grant from the National Cancer Institute (NCI) to study cognitive dysfunction after chemotherapy.
AstraZeneca today announced that it submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for approval of a new indication for SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). SYMBICORT is currently approved for the long-term maintenance treatment of asthma in patients 12 years and older.
› Verified 2 days ago
Mr. Matthew Earl Kyer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 200 Herlong Ave S Ste A, Rock Hill, SC 29732 Phone: 803-328-1864 | |
Ms. Erika Ann Nager Rakhar, P.A.-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 200 Herlong Ave S Ste B, Rock Hill, SC 29732 Phone: 803-324-3500 | |
Shannon Lynn Egan, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1656 Riverchase Blvd, Ste 1400, Rock Hill, SC 29732 Phone: 803-329-9088 | |
Kim Nathan, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1656 Riverchase Blvd, Ste 1400, Rock Hill, SC 29732 Phone: 803-329-9088 | |
Heather Nicole Mchenry, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 200 S Herlong Ave Ste B, Rock Hill, SC 29732 Phone: 803-324-1950 Fax: 803-324-1933 | |
Rosalind Valerie Becker, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1656 Riverchase Blvd, Ste 2400, Rock Hill, SC 29732 Phone: 803-329-5131 | |
Caroline Whitesides Webster, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 222 Herlong Ave S, Rock Hill, SC 29732 Phone: 803-329-1234 |